Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigid S Boland

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Gastroenterology Clinics of North America|August 26, 2017
Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's DiseaseBrigid S Boland, Séverine Vermeire
Current Treatment Options in Gastroenterology|August 14, 2017
Endoscopic Surveillance in Long-standing ColitisBrigid S Boland, Amandeep Shergill, Tonya Kaltenbach
Gastroenterology Clinics of North America|August 12, 2014
Update on Janus kinase antagonists in inflammatory bowel diseaseBrigid S Boland, William J Sandborn, John T Chang
Endocrinology and Metabolism Clinics of North America|November 30, 2013
Gastrointestinal complications of diabetesBrigid S Boland, Steven V Edelman, James D Wolosin
The Lancet. Gastroenterology & Hepatology|January 20, 2023
Management of inflammatory bowel diseases in older adultsSiddharth Singh, Brigid S Boland, Tine Jess, et al.
Journal of Crohn'S & Colitis|January 26, 2018
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysisSiddharth Singh, John George, Brigid S Boland, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
FORWARD: A Learning Framework for Logical Network Perturbations to Prioritize Targets for Drug DevelopmentSaptarshi Sinha, Ella McLaren, Madhubanti Mullick, et al.
Journal of Clinical and Experimental Hepatology|October 21, 2014
Association of serum bilirubin with aging and mortalityBrigid S Boland, Mamie H Dong, Ricki Bettencourt, et al.
Inflammatory Bowel Diseases|February 3, 2016
How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel DiseaseParambir S Dulai, Siddharth Singh, Niels V Casteele, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2025
Efficacy of Advanced Therapies in Achieving Remission by Disease Location in Crohn's Disease: A Systematic Review and Meta-analysisHan Hee Lee, Yuhong Yuan, Brigid S Boland, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Gastroenterology Clinics of North America|August 26, 2017
Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's DiseaseBrigid S Boland, Séverine Vermeire
Current Treatment Options in Gastroenterology|August 14, 2017
Endoscopic Surveillance in Long-standing ColitisBrigid S Boland, Amandeep Shergill, Tonya Kaltenbach
Gastroenterology Clinics of North America|August 12, 2014
Update on Janus kinase antagonists in inflammatory bowel diseaseBrigid S Boland, William J Sandborn, John T Chang
Endocrinology and Metabolism Clinics of North America|November 30, 2013
Gastrointestinal complications of diabetesBrigid S Boland, Steven V Edelman, James D Wolosin
The Lancet. Gastroenterology & Hepatology|January 20, 2023
Management of inflammatory bowel diseases in older adultsSiddharth Singh, Brigid S Boland, Tine Jess, et al.
Journal of Crohn'S & Colitis|January 26, 2018
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysisSiddharth Singh, John George, Brigid S Boland, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
FORWARD: A Learning Framework for Logical Network Perturbations to Prioritize Targets for Drug DevelopmentSaptarshi Sinha, Ella McLaren, Madhubanti Mullick, et al.
Journal of Clinical and Experimental Hepatology|October 21, 2014
Association of serum bilirubin with aging and mortalityBrigid S Boland, Mamie H Dong, Ricki Bettencourt, et al.
Inflammatory Bowel Diseases|February 3, 2016
How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel DiseaseParambir S Dulai, Siddharth Singh, Niels V Casteele, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2025
Efficacy of Advanced Therapies in Achieving Remission by Disease Location in Crohn's Disease: A Systematic Review and Meta-analysisHan Hee Lee, Yuhong Yuan, Brigid S Boland, et al.
Pageof 10